The 4C Biomed group is a biomed R&D start-up in the field of Immuno-Oncology operating in the UK through 4C Biomed Inc, supported in Israel through its wholly owned service company, 4C Biomed Services Ltd. Our vision is to become a leading drug discovery group in the field of cancer immuno-therapy. Our main objective is to identify accurately targets that enable us to develop novel and potent drugs. Our drugs are aimed at harnessing a patient's own immune system to fight cancer efficiently.